Serum Urate Goals Tied to Lower CV Risk - Takeaways - MDSpire

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

  • By

  • Andrea Surnit

  • May 11, 2026

  • 4 min

Share

  • 1

    Achieving serum urate targets with urate-lowering therapy reduces the 5-year risk of major adverse cardiovascular events in gout patients.

  • 2

    In a study of 109,504 adults, those who reached urate levels below 6 mg/dL had a hazard ratio of 0.91 for cardiovascular events.

  • 3

    Patients achieving urate levels below 5 mg/dL showed an even stronger association, with a hazard ratio of 0.77 and a 3 percentage point survival difference.

  • 4

    The study highlights a potential link between gout flares, systemic inflammation, and cardiovascular risk, rather than urate lowering alone.

  • 5

    Despite adjustments, residual confounding may affect results, and fewer than one-third of patients achieved target urate levels within the first year.

Original Source(s)

Serum Urate Goals Tied to Lower CV Risk

  • by Andrea Surnit

  • May 11, 2026

Related Content

Machine learning-based prediction of gout flares during hospitalization in patients with upper gastrointestinal bleeding: a retrospective cohort study

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Do Urate Targets Influence CV Risk?

Researchers examine whether achieving treat-to-target serum urate levels with urate-lowering treatment affects long-term cardiovascular outcomes in patients with gout.